CIK: 1260882 - Address: C/o Acura Pharmaceuticals, Inc., 616 N. North Court, Suite 120, Palantine, IL 60067
2 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

4/6/11 12:05
4/4/11
ACURAcura Pharmaceuticals, IncNYHealthDrugPharmaceutical PreparationsReddick Andrew DILDOP,CEOM.d1461.300113121,037D-36-34651327362827269-7-4-17
11/25/09 15:58
11/24/09
ACURAcura Pharmaceuticals, IncNYHealthDrugPharmaceutical PreparationsReddick Andrew DILDOP,CEOM.d5531.300425641,086D-41-24-40-26-81078662211-23-40

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact